Effectiveness of Mindfulness-Based Interventions on Breathlessness in Lung Cancer: A Meta-Analysis.
메타분석
3/5 보강
TL;DR
Mindfulness-based interventions did not demonstrate a statistically significant improvement in self-reported breathlessness compared to controls, however, subgroup analysis indicated that combining mindfulness with respiratory function training may offer additional benefits for alleviating breathlessness.
OpenAlex 토픽 ·
Cancer survivorship and care
Chronic Obstructive Pulmonary Disease (COPD) Research
Mindfulness and Compassion Interventions
Mindfulness-based interventions did not demonstrate a statistically significant improvement in self-reported breathlessness compared to controls, however, subgroup analysis indicated that combining mi
- 표본수 (n) 1190
- 95% CI -0.92 to 0.05
- 연구 설계 systematic review
APA
Yueying Wang, Yan Li, et al. (2026). Effectiveness of Mindfulness-Based Interventions on Breathlessness in Lung Cancer: A Meta-Analysis.. Journal of pain and symptom management, 71(4), e405-e419. https://doi.org/10.1016/j.jpainsymman.2025.11.018
MLA
Yueying Wang, et al.. "Effectiveness of Mindfulness-Based Interventions on Breathlessness in Lung Cancer: A Meta-Analysis.." Journal of pain and symptom management, vol. 71, no. 4, 2026, pp. e405-e419.
PMID
41344543 ↗
Abstract 한글 요약
[CONTEXT] Breathlessness is the most common and distressing symptom in lung cancer, but no systematic review has examined the effectiveness of mindfulness-based interventions on breathlessness.
[OBJECTIVES] To evaluate the effectiveness of mindfulness-based interventions on breathlessness, pulmonary function, and psychological well-being in lung cancer.
[METHODS] According to the PRISMA guidelines, we conducted a systematic search across ten databases from inception to February 2025. Only randomized controlled trials were included.
[RESULTS] Fourteen RCTs from 15 papers (N = 1190) were included. Pooled results: compared with a control, mindfulness-based interventions did not show a significant improvement in breathlessness [SMD = -0.44, 95% CI: -0.92 to 0.05, n = 5]; indicated a significant improvement in pulmonary function including vital capacity [MD = 0.44 L, 95% CI: 0.18-0.70, n = 2], peak expiratory flow [MD = 14.72 L/s, 95% CI: 6.14-23.30, n = 2], forced expiratory volume in one second (FEV) [MD = 0.49 L, 95% CI: 0.17-0.81, n = 9], forced vital capacity (FVC) [MD = 0.55 L, 95% CI: 0.28-0.83, n = 8], FEV/FVC [MD = 8.02%, 95% CI: 5.77-10.28, n = 6]; indicated a significant reduction in psychological distress including depressive symptoms [SMD = -1.28, 95% CI: -2.25 to -0.31, n = 6], and anxiety [SMD = -1.54, 95% CI: -2.34 to -0.74, n = 7]. Subgroup analysis: patients receiving mindfulness-based respiratory function interventions indicated significant improvements in breathlessness [SMD = -0.53, 95% CI: -0.86 to -0.21], FEV [MD = 0.28 L, 95% CI: 0.17-0.39], and FVC [MD = 1.29, 95% CI: 0.64-1.95], compared with those receiving respiratory function intervention.
[CONCLUSION] Mindfulness-based interventions did not demonstrate a statistically significant improvement in self-reported breathlessness compared to controls. However, subgroup analysis indicated that combining mindfulness with respiratory function training may offer additional benefits for alleviating breathlessness. Further high-quality RCTs are needed to determine the optimal intervention dosages and long-term impact of mindfulness-based interventions on improving breathlessness.
[OBJECTIVES] To evaluate the effectiveness of mindfulness-based interventions on breathlessness, pulmonary function, and psychological well-being in lung cancer.
[METHODS] According to the PRISMA guidelines, we conducted a systematic search across ten databases from inception to February 2025. Only randomized controlled trials were included.
[RESULTS] Fourteen RCTs from 15 papers (N = 1190) were included. Pooled results: compared with a control, mindfulness-based interventions did not show a significant improvement in breathlessness [SMD = -0.44, 95% CI: -0.92 to 0.05, n = 5]; indicated a significant improvement in pulmonary function including vital capacity [MD = 0.44 L, 95% CI: 0.18-0.70, n = 2], peak expiratory flow [MD = 14.72 L/s, 95% CI: 6.14-23.30, n = 2], forced expiratory volume in one second (FEV) [MD = 0.49 L, 95% CI: 0.17-0.81, n = 9], forced vital capacity (FVC) [MD = 0.55 L, 95% CI: 0.28-0.83, n = 8], FEV/FVC [MD = 8.02%, 95% CI: 5.77-10.28, n = 6]; indicated a significant reduction in psychological distress including depressive symptoms [SMD = -1.28, 95% CI: -2.25 to -0.31, n = 6], and anxiety [SMD = -1.54, 95% CI: -2.34 to -0.74, n = 7]. Subgroup analysis: patients receiving mindfulness-based respiratory function interventions indicated significant improvements in breathlessness [SMD = -0.53, 95% CI: -0.86 to -0.21], FEV [MD = 0.28 L, 95% CI: 0.17-0.39], and FVC [MD = 1.29, 95% CI: 0.64-1.95], compared with those receiving respiratory function intervention.
[CONCLUSION] Mindfulness-based interventions did not demonstrate a statistically significant improvement in self-reported breathlessness compared to controls. However, subgroup analysis indicated that combining mindfulness with respiratory function training may offer additional benefits for alleviating breathlessness. Further high-quality RCTs are needed to determine the optimal intervention dosages and long-term impact of mindfulness-based interventions on improving breathlessness.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- "I wanna look like the person in that picture": Linking selfies on social media to cosmetic surgery consideration based on the tripartite influence model.
- ZmSKIP enhances drought tolerance by reducing stomatal aperture in maize.
- c.7374_7375insAlu is a French-Canadian founder pathogenic variant associated with predisposition to pancreatic and breast cancer.
- Enhancing Node-RADS for preoperative assessment of cervical lymph node metastases in papillary thyroid carcinoma: validation and modification.
- Aging modulation of the immune system and immunotherapy efficacy in cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.